Register for updates

 
 

Medicine & Health
RSS Feed
Anti-Inflammatory, Anti-Stress Drugs Taken Prior to Surgery May Reduce Metastatic Recurrence
Monday, August 07, 2017 9:00:00 AM

The body's stress inflammatory response is an active agent of cancer metastasis, TAU researchers say

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

A new Tel Aviv University study finds that a specific drug regimen administered prior to and after surgery significantly reduces the risk of post-surgical cancer recurrence. These medications, a combination of a beta blocker (which relieves stress and high blood pressure) and an anti-inflammatory, may also improve the long-term survival rates of patients. The treatment is safe, inexpensive — two medications similar in price to aspirin — and easily administered to patients without contraindications.

The research was led by Prof. Shamgar Ben-Eliyahu of TAU's School of Psychological Sciences and Sagol School of Neuroscience in collaboration with Prof. Steven Cole of UCLA; Prof. Oded Zmora of Sheba Medical Center, Tel Hashomer; Prof. Eran Sharon of Rabin Medical Center, Beilinson; and Prof. Tanir Ellweiss of Kaplan Medical Center. It was published in Clinical Cancer Research.

Deviating from dogma

"We've taken an unconventional approach, deviating from the current medical dogma that refrains from intervening during the short period surrounding a cancer surgery — no chemo, radio or immune therapy for at least three weeks before or after surgery," Prof. Ben-Eliyahu said. "Even within the medical establishment, we encountered some levels of disbelief and antagonism. But after conducting ample studies in animal models of cancer, and reviewing the medical literature, we came to the firm conclusion that maybe this is the most important period in the prevention of cancer recurrence."

For the study, 38 breast cancer patients at Sheba Medical Center, Kaplan Medical Center and Rabin Medical Center were given a pharmacological treatment — Deralin (used to reduce blood pressure and anxiety) and Etopan (used to reduce inflammation) — five days before their surgeries, the day of their surgeries and five days after their surgeries. Blood and tumor tissue samples were then analyzed using whole genome gene expression profiling to identify all the RNAs expressed in malignant cells and leukocytes.

"We found that the drugs were very efficient in reducing biomarkers of metastatic processes," Prof. Ben-Eliyahu said. "For example, we found that the drug treatment reverses EMT — the process that tumor cells go through to slip out of the primary tumor and enter another organ. It is a crucially important step in the metastatic process. We also looked at indices related to the immune system and were able to improve immune competence and reduce inflammation with the drugs."

The research team has conducted a similar study, which has not yet been published, on colorectal cancer patients and has found similar results.

The researchers are currently considering a larger-scale clinical trial to establish the clinical long-term beneficial effects of this treatment. "Positive outcomes should validate this treatment and lead to its becoming available for most cancer patients," Prof. Ben-Eliyahu concluded.




Latest News

AFTAU to Celebrate the Steve Tisch School of Film & Television at Annual Gala Dinner

Philanthropist and producer Steve Tisch to be honored; prominent industry leaders to serve as vice chairs.

Children's Exposure to Secondhand Smoke May Be Vastly Underestimated by Parents

Smoking parents misperceive where and when their kids are exposed to cigarette smoke, TAU researchers say.

Your Stress and Mine

TAU study assesses how we perceive other people's stress levels in the workplace.

Consumption of Nicotine in Adolescence May Lead to Increased Alcohol Intake Later in Life

Nicotine "memories" from adolescence may lead to alcoholism years later, TAU researchers say.

When You're Tired, Your Brain Cells Actually Slow Down

Sleep rhythms can disrupt normal activity in specific regions of the brain, say TAU, UCLA and UW researchers.

TAU Hosts First Zuckerman US-Israel Symposium

Supporting future generations of STEM leaders, Zuckerman scholarship programs engage top-tier talent.

Mammals Switched to Daytime Activity After Dinosaur Extinction

Change occurred during a stage of mixed day and night activity over millions of years, TAU and University College London researchers say.

Navigating the Genome to Cure Deafness

Discovery of long-encoding RNAs in the auditory system may solve a piece of the deafness puzzle, TAU researcher says.

Young Bats Learn Bat "Dialects" from Their Nestmates

Research proves language acquisition not limited to human beings, TAU researchers say.

Reptile Atlas Pinpoints Areas of Conservation Concern

New reptile map completes planet's "atlas of life," TAU researchers say.

contentSecondary
c

© 2017 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University